Representative before the EPO until 2017

Company dna ep and c
operating since 1939
6 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 4 EP applications René John Raggers has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after February 21, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11778231

IMMUNOTHERAPY USING REDIRECTED ALLOGENEIC CELLS

IPC classification:
C12N 5/02, C12N 15/11
Applicant:
Yeda Research and Development Co. Ltd.
Agent:
René John Raggers, Exter Polak & Charlouis B.V. (EP & C)
Status:
GRANT OF PATENT INTENDED
EP13795879

MEDICAL DEVICES WITH COATINGS FOR ENHANCED ECHOGENICITY

IPC classification:
A61L 31/08, A61L 31/18
Agent:
Cornelis Marinus Jansen, Vereenigde Octrooibureaux NV (V.O.)
Agent:
René John Raggers, Exter Polak & Charlouis B.V. (EP & C)
Status:
GRANT OF PATENT INTENDED
EP11725992

MIRNAS INVOLVED IN THE BLOOD BRAIN BARRIER FUNCTION

IPC classification:
A61K 31/713, A61P 25/00, A61P 27/02, A61P 31/18, A61P 35/00, C12N 15/113, C12Q 1/68
Applicant:
VUvereiniging (Vereniging voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek en Patiëntenzorg)
Agent:
Thea van der Wijk, Nederlandsch Octrooibureau N.V.
Agent:
René John Raggers, Exter Polak & Charlouis B.V. (EP & C)
Status:
GRANT OF PATENT INTENDED
EP12193811

An improved mutagenesis method using polyethylene glycol mediated introduction of mutagenic nucleobases into plant protoplasts

IPC classification:
C12N 15/82
Applicant:
Keygene N.V.
Agent:
René John Raggers, Exter Polak & Charlouis B.V. (EP & C)
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature